All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.

The ALL Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your ALL Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The ALL Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the ALL Hub cannot guarantee the accuracy of translated content. The ALL Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.

Mark LitzowSteering Committee Member

Mark Litzow is a professor of medicine at the Mayo Clinic. He served as the head of the Acute Leukemia and Myeloid Neoplasm Group at Mayo Clinic's campus in Rochester, Minnesota, for 12 years and the director of the Blood and Marrow Transplant (BMT) Program at Mayo Clinic for 17 years; he remains an active member of both programs. Mark is the chair of the Leukemia Committee of Eastern Cooperative Oncology Group and the American College of Radiology Imaging Network (ECOG-ACRIN) since 2013. He is also currently the co-chair of the Acute Leukemia Working Committee for the Center for International Blood and Marrow Transplant Research (CIBMTR).

||